EntryPoint Capital’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,084
Closed -$211K 665
2025
Q1
$211K Buy
3,084
+305
+11% +$24.9K 0.1% 507
2024
Q4
$216K Buy
+2,779
New +$206K 0.09% 563
2024
Q3
Sell
-1,129
Closed -$128K 756
2024
Q2
$128K Buy
+1,129
New +$143K 0.19% 197
2024
Q1
Sell
-1,084
Closed -$135K 1507
2023
Q4
$135K Buy
+1,084
New +$111K 0.13% 240

Other funds holding DXCM

EntryPoint Capital's DXCM Position: Q2 2025 in Review

EntryPoint Capital sold out of DexCom (DXCM) in Q2 2025, closing a stake of 3,084 shares — an estimated $211K sold.

EntryPoint Capital first reported a position in DXCM in Q4 2023 and held it in 4 quarters. The position peaked at $216K in Q4 2024. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • EntryPoint Capital reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • EntryPoint Capital sold 3,084 DexCom shares in Q2 2025, an estimated $211K.
  • EntryPoint Capital first reported a position in DexCom in Q4 2023 and held it in 4 quarters.
  • EntryPoint Capital's DexCom position peaked at $216K in Q4 2024.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on EntryPoint Capital's 13F filing for Q2 2025, filed 11 Aug 2025.